REPL
REPL
NASDAQ · Biotechnology

Replimune Group Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$13.07
+0.20 (+1.55%)
As of Sep 20, 10:22 PM ET ·
Earnings History
Date Quarter EPS Est EPS Actual Surprise Surprise % Result
Aug 5, 2026 Q3 FY2026 $-0.68 — — — —
Jun 12, 2026 Q2 FY2026 $-0.73 — — — —
May 20, 2026 Q2 FY2026 $-0.71 — — — —
Feb 10, 2026 Q1 FY2026 $-0.91 — — — —
Related Earnings News
FDA Panel Nod Sparks $763M Value Shift Between Melanoma Drugmakers
Regulation ·
Replimune Surges 107% as FDA Panel Backs RP1 Despite Data Discrepancies
Analysis ·
Replimune Rockets 131% on FDA Panel Backing for RP1
Markets ·
Replimune Surges 85% on FDA Priority Review for Melanoma Drug
Markets ·